April 2025, smaller-cap indexes like the S&P MidCap 400 and Russell 2000 have shown resilience by posting gains, even as large-cap tech stocks in the U.S. faced headwinds due to new trade restrictions ...

The biopharmaceutical industry is positioned for continued recovery, driven by recent FDA approvals and billion-dollar ...

Pittsburgh biotech firms see potential benefits from upcoming tariffs and reshoring efforts, despite uncertainties in NIH ...

Bristol-Myers Squibb Company's Q1 2025 earnings reveal revenue decline but EPS growth. Click to discover BMY challenges, ...

Pharma executives emphasise that without urgent action, Europe may face a decline and an acceleration in the departure of ...

Global Data has revealed that the Top 20 Global Biopharmaceutical Companies have witnessed a 6 % growth in market ...

Many investors pay attention to mid-cap stocks because they have established business models and expansive market ...

Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...

Ladenburg, Germany, 24 April 2025 - Heidelberg Pharma AG (FSE: HPHA) today reported on the first three months of fiscal year 2025 (1 December 2024 – 28 February 2025) and the Group’s financial figures ...

European drug company bosses say the answer to a perceived lack of competitiveness in the EU is to hike medicine prices to US ...

European drugmakers are urging the EU to allow higher medicine prices, warning that without stronger investment incentives, ...

GE Aerospace ( NYSE:GE) is the largest industrials company, followed by RTX Corporation ( NYSE:RTX) and Caterpillar ( ...